Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
暂无分享，去创建一个
E. Winer | R. Gelber | L. Trippa | Minetta C. Liu | R. Bose | B. Ramaswamy | V. Valero | H. Rugo | A. Wolff | H. Burstein | N. Tung | K. Marcom | William H. Barry | R. Nanda | L. Hart | K. Albain | D. Yardley | P. Pohlmann | S. Isakoff | Yue Zheng | K. Ruddy | A. Partridge | Shoshana M. Rosenberg | B. Schneider | T. Mulvey | V. Abramson | S. Tolaney | C. V. Van Poznak | V. Gadi | I. Krop | R. Jankowitz | A. Forero-Torres | N. Tayob | D. Weckstein | C. Dang | M. Rimawi | B. Ardman | A. Garrett | Kit Cheng | Jiani Hu | D. Zuckerman | Michael Constantine | M. Demeo | M. Faggen | F. Briccetti | P. Defusco | K. Reeder-Hayes